Diamyd Medical Balance Sheet Health
Financial Health criteria checks 6/6
Diamyd Medical has a total shareholder equity of SEK181.2M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK226.5M and SEK45.3M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr137.15m |
| Equity | kr181.22m |
| Total liabilities | kr45.26m |
| Total assets | kr226.48m |
Recent financial health updates
We're Keeping An Eye On Diamyd Medical's (STO:DMYD B) Cash Burn Rate
Feb 02
We Think Diamyd Medical (STO:DMYD B) Needs To Drive Business Growth Carefully
Sep 22Recent updates
We're Keeping An Eye On Diamyd Medical's (STO:DMYD B) Cash Burn Rate
Feb 02We Think Diamyd Medical (STO:DMYD B) Needs To Drive Business Growth Carefully
Sep 22What You Need To Know About Diamyd Medical AB (publ)'s (STO:DMYD B) Investor Composition
Jan 22Here's Why Diamyd Medical's (STO:DMYD B) Statutory Earnings Are Arguably Too Conservative
Nov 30Financial Position Analysis
Short Term Liabilities: DMYD B's short term assets (SEK159.8M) exceed its short term liabilities (SEK20.5M).
Long Term Liabilities: DMYD B's short term assets (SEK159.8M) exceed its long term liabilities (SEK24.7M).
Debt to Equity History and Analysis
Debt Level: DMYD B is debt free.
Reducing Debt: DMYD B has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DMYD B has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: DMYD B has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 29.7% each year.